McKesson Corporation (MCK)EVP & Chief HR Officer sold ~$115K

~$115K

Approx. value · 188 sh @ $609.59

1,051

Holds after · shares reported

Traded

Feb 12, 2025

Filed

Feb 13, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 2, 2025InsiderOfficer sold ~$332K of MCK shares in the open market
2. Jan 15, 2025Congress · 1 personMembers of Congress: 2 purchases
3. Jan 24, 2025CongressDisclosed sale of MCK — reported range $1,001 - $15,000
4. Feb 12, 2025 · this disclosureInsiderOfficer sold ~$115K of MCK shares in the open market

What came next

1. Feb 14, 2025InsiderCEO sold ~$5.38M of MCK shares in the open market
2. Feb 21, 2025InsiderCEO sold ~$5.36M of MCK shares in the open market
3. Feb 25, 2025InsiderOfficer sold ~$189K of MCK shares in the open market
4. Feb 28, 2025InsiderCEO sold ~$5.59M of MCK shares in the open market
5. Mar 4, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
6. Mar 6, 2025InsiderCEO sold ~$5.68M of MCK shares in the open market
7. Apr 9, 2025CongressDisclosed partial sale of MCK — reported range $1,001 - $15,000
8. Apr 24, 2025FDARecall: SEKISUI DIAGNOSTICS LLC SERUM HCG OSOMGENZME CONTROL SET.
9. Apr 24, 2025FDARecall: ABBOTT POINT OF CARE TEST CREA I-STAT (25/BX) ABBTPT CARTRIDGE.
10. Apr 24, 2025FDARecall: ORTHO CLINICAL DIAGNOSTICS INC ANTI-B BIOCLONE 10ML3X10ML.
11. Apr 24, 2025FDARecall: ORTHO CLINICAL DIAGNOSTICS INC VITROS BUN (60/CR 5CR/PK) ORCLNL REAGENT.
12. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARCH AUSAB ANTI-HBS (100/EA) REAGENT.
13. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARCHITECT PROGESTERONE (100TESTS) REAGENT.
14. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARCHITECT FREE T4ABBDIA CALIBRATOR.
15. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARC ANTI-TPO ASSAY 100TST B REAGENT.
16. Apr 24, 2025FDARecall: ABBOTT RAPID DX N AMERICA LLC, TEST CHOLESTEC LDXLIPID PROFILE (10/BX 50BX/CS) CASSETTES.
17. Apr 24, 2025FDARecall: HEMOCUE INC GLUC AQUEOUS 1HI/LO HEMCUE CONTROL KIT.
18. Apr 24, 2025FDARecall: ORTHO CLINICAL DIAGNOSTICS INC VITROS CALCIUM (L-SEQUESTER) (300/PK) REAGENT.
19. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARC CARBON DIOXIDE6X5ML B CALIBRATOR.
20. Apr 24, 2025FDARecall: BD MICROBIOLOGY FLUID THIOGLYCOLLATE MED TUBE 1004321196 (100/CT) MEDIA.

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for McKesson Corporation

For McKesson Corporation, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports, 47 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MCK page.

Other recent filings by Leann B Smith, EVP & Chief HR Officer

• SEC Form 4 at McKesson Corporation (MCK)Jun 2, 2026
• SEC Form 4 at McKesson Corporation (MCK)Feb 19, 2026
• SEC Form 4 at McKesson Corporation (MCK)May 29, 2025
• SEC Form 4 at McKesson Corporation (MCK)May 28, 2025
• SEC Form 4 at McKesson Corporation (MCK)May 23, 2025

The full history of Leann B Smith, EVP & Chief HR Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at McKesson Corporation

• USAspending.gov award recordOct 5, 2026
• SEC Form 4Sep 10, 2026
• USAspending.gov award recordSep 4, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its MCK page.